TIPE2 inhibits TNF-α-induced hepatocellular carcinoma cell metastasis via Erk1/2 downregulation and NF-κB activation

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• Tumor necrosis factor-α-induced protein 8-like 2 (TIPE2) is a negative regulator of immune homeostasis.
• Pro-inflammatory cytokines like TNF-α are implicated in liver carcinoma metastasis, but TIPE2's role is unknown.

Purpose of the Study:

• To investigate the effect of TIPE2 on hepatocellular carcinoma (HCC) metastasis.
• To elucidate the molecular mechanisms underlying TIPE2's influence on TNF-α-induced HCC progression.

Main Methods:

• HepG2 cells were used to study TNF-α-induced expression of MMP-13/MMP-3 and cell migration.
• The involvement of Erk1/2-NF-κB pathways was assessed.
• The impact of TIPE2 overexpression on TNF-α secretion and downstream signaling was examined following LPS treatment.

Main Results:

• TNF-α augmented MMP-13/MMP-3 expression and promoted HepG2 cell migration via Erk1/2-NF-κB activation.
• Liver cancer cells, PBLs, macrophages, and fibroblasts express TNF-α after LPS treatment.
• TIPE2 overexpression inhibited LPS-induced TNF-α secretion and abolished TNF-α's effects on MMPs, migration, and Erk1/2-NF-κB activation.

Conclusions:

• TIPE2 suppresses TNF-α-induced HCC metastasis by inhibiting Erk1/2 and NF-κB activation.
• Both TNF-α and TIPE2 represent potential therapeutic targets for HCC metastasis.